Smriti Gadia
YOU?
Author Swipe
View article: Macronutrient Intake and Dietary Patterns in Indian Adults with and without Type 2 Diabetes: Findings From the Multicentric I-STARCH-1 Study
Macronutrient Intake and Dietary Patterns in Indian Adults with and without Type 2 Diabetes: Findings From the Multicentric I-STARCH-1 Study Open
The I-STARCH (Indian Study to Assess Real-World CarboHydrate Consumption) investigation quantified decadal changes in macronutrient intake and carbohydrate quality among Indian adults by benchmarking a 2025 multicentric cross-sectional sur…
View article: The GOLD-PCP Study: Clinician Insights on Person-Centric Packaging Design of a Triple Fixed-Dose Combination in Type 2 Diabetes Care
The GOLD-PCP Study: Clinician Insights on Person-Centric Packaging Design of a Triple Fixed-Dose Combination in Type 2 Diabetes Care Open
Clinicians perceived PCP as beneficial for adherence support and therapy management in type 2 diabetes. However, further patient-centered studies using objective adherence metrics are needed to validate these perceptions and determine caus…
View article: Early Introduction of SGLT-2 Inhibitors to Improve Chronic Kidney Disease Care in People with or without Diabetes—Consensus by Indian Nephrologists
Early Introduction of SGLT-2 Inhibitors to Improve Chronic Kidney Disease Care in People with or without Diabetes—Consensus by Indian Nephrologists Open
Introduction: Chronic kidney disease (CKD) is a progressive condition characterized by reduced kidney function, leading to increased morbidity and mortality. The risk of cardiovascular disease is notably high among individuals with CKD and…
View article: Effects of SGLT2i and Pioglitazone on FIB-4 Index in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease—A Real World Retrospective Study from India
Effects of SGLT2i and Pioglitazone on FIB-4 Index in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease—A Real World Retrospective Study from India Open
Aims: Several studies support type 2 diabetes mellitus (T2DM) as one of the risk factors of metabolic dysfunction associated steatotic liver disease (MASLD). Recently, the use of pioglitazone and sodium-glucose co-transporter 2 inhibitors …